---
schema_version: "secwatch.filing_event.v1"
accession: "0000012208-23-000035"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2023-02-23T23:59:59+00:00"
generated_at: "2026-06-19T01:37:10.757375+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad discloses Sartorius AG 2022 financials: sales €4.17B, net profit €913M

## Summary
- Sartorius AG reported 2022 sales revenue of €4,174.7M and gross profit of €2,196.5M.
- EBIT of €1,064.8M and net profit of €913.1M for the year ended December 31, 2022.
- Cash flow from operations €734.2M; investing activities used €1,129.9M.
- Total equity at year-end €2,658.9M; current assets €2,023.2M, current liabilities €1,803.4M.
- Data sourced from Sartorius's IFRS consolidated financial statements publicly disclosed on Feb 17, 2023.

## SEC filing metadata
- accession: 0000012208-23-000035
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2023-02-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000001220823000035/0000012208-23-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000001220823000035/bio-20230223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000012208-23-000035
- JSON: https://secwatch.observer/filing/0000012208-23-000035.json
- Plain text: https://secwatch.observer/filing/0000012208-23-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.